• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于评估群体药代动力学设计的群体费舍尔信息矩阵的开发与实施。

Development and implementation of the population Fisher information matrix for the evaluation of population pharmacokinetic designs.

作者信息

Retout S, Duffull S, Mentré F

机构信息

INSERM U436, CHU Pitié-Salpétrière, 91 Bd de l'Hôpital, 75013, Paris, France.

出版信息

Comput Methods Programs Biomed. 2001 May;65(2):141-51. doi: 10.1016/s0169-2607(00)00117-6.

DOI:10.1016/s0169-2607(00)00117-6
PMID:11275334
Abstract

In population pharmacokinetic studies, the precision of parameter estimates is dependent on the population design. Methods based on the Fisher information matrix have been developed and extended to population studies to evaluate and optimize designs. In this paper we propose simple programming tools to evaluate population pharmacokinetic designs. This involved the development of an expression for the Fisher information matrix for nonlinear mixed-effects models, including estimation of the variance of the residual error. We implemented this expression as a generic function for two software applications: S-PLUS and MATLAB. The evaluation of population designs based on two pharmacokinetic examples from the literature is shown to illustrate the efficiency and the simplicity of this theoretic approach. Although no optimization method of the design is provided, these functions can be used to select and compare population designs among a large set of possible designs, avoiding a lot of simulations.

摘要

在群体药代动力学研究中,参数估计的精度取决于群体设计。基于费舍尔信息矩阵的方法已得到发展并扩展到群体研究中,以评估和优化设计。在本文中,我们提出了简单的编程工具来评估群体药代动力学设计。这涉及为非线性混合效应模型开发费舍尔信息矩阵的表达式,包括估计残余误差的方差。我们将此表达式实现为两个软件应用程序(S-PLUS和MATLAB)的通用函数。通过对文献中两个药代动力学实例的群体设计评估,展示了这种理论方法的效率和简便性。尽管未提供设计的优化方法,但这些函数可用于在大量可能的设计中选择和比较群体设计,避免大量模拟。

相似文献

1
Development and implementation of the population Fisher information matrix for the evaluation of population pharmacokinetic designs.用于评估群体药代动力学设计的群体费舍尔信息矩阵的开发与实施。
Comput Methods Programs Biomed. 2001 May;65(2):141-51. doi: 10.1016/s0169-2607(00)00117-6.
2
PFIM 4.0, an extended R program for design evaluation and optimization in nonlinear mixed-effect models.PFIM 4.0,一个用于非线性混合效应模型设计评估和优化的扩展 R 程序。
Comput Methods Programs Biomed. 2018 Mar;156:217-229. doi: 10.1016/j.cmpb.2018.01.008. Epub 2018 Jan 11.
3
Fisher information matrix for non-linear mixed-effects models: evaluation and application for optimal design of enoxaparin population pharmacokinetics.非线性混合效应模型的费舍尔信息矩阵:依诺肝素群体药代动力学优化设计的评估与应用
Stat Med. 2002 Sep 30;21(18):2623-39. doi: 10.1002/sim.1041.
4
Fisher information matrix for nonlinear mixed effects multiple response models: evaluation of the appropriateness of the first order linearization using a pharmacokinetic/pharmacodynamic model.非线性混合效应多响应模型的费希尔信息矩阵:使用药代动力学/药效学模型评估一阶线性化的适用性
Stat Med. 2009 Jun 30;28(14):1940-56. doi: 10.1002/sim.3573.
5
Optimal sampling times for a drug and its metabolite using SIMCYP(®) simulations as prior information.使用 SIMCYP(®) 模拟作为先验信息确定药物及其代谢物的最佳采样时间。
Clin Pharmacokinet. 2013 Jan;52(1):43-57. doi: 10.1007/s40262-012-0022-9.
6
Optimal design of mixed-effects PK/PD models based on differential equations.
J Biopharm Stat. 2012;22(1):180-205. doi: 10.1080/10543406.2010.513465.
7
A pragmatic approach to the design of population pharmacokinetic studies.一种用于群体药代动力学研究设计的实用方法。
AAPS J. 2005 Oct 5;7(2):E408-20. doi: 10.1208/aapsj070241.
8
Influence of the Size of Cohorts in Adaptive Design for Nonlinear Mixed Effects Models: An Evaluation by Simulation for a Pharmacokinetic and Pharmacodynamic Model for a Biomarker in Oncology.非线性混合效应模型自适应设计中样本量的影响:针对肿瘤学生物标志物的药代动力学和药效学模型的模拟评估
Pharm Res. 2015 Oct;32(10):3159-69. doi: 10.1007/s11095-015-1693-3. Epub 2015 Jun 30.
9
Design of population pharmacokinetic experiments using prior information.利用先验信息设计群体药代动力学实验。
Xenobiotica. 2007 Oct-Nov;37(10-11):1311-30. doi: 10.1080/00498250701553315.
10
Influence of covariance between random effects in design for nonlinear mixed-effect models with an illustration in pediatric pharmacokinetics.非线性混合效应模型设计中随机效应协方差的影响及儿科药代动力学实例分析
J Biopharm Stat. 2014;24(3):471-92. doi: 10.1080/10543406.2014.888443.

引用本文的文献

1
Tutorial on model selection and validation of model input into precision dosing software for model-informed precision dosing.模型选择和验证教程,用于将模型输入到精准给药软件中,以实现基于模型的精准给药。
CPT Pharmacometrics Syst Pharmacol. 2023 Dec;12(12):1827-1845. doi: 10.1002/psp4.13056. Epub 2023 Oct 12.
2
Optimized Rhombic Experimental Dynamic Checkerboard Designs to Elucidate Pharmacodynamic Drug Interactions of Antibiotics.优化的菱形实验动态棋盘设计,阐明抗生素的药效学药物相互作用。
Pharm Res. 2022 Dec;39(12):3267-3277. doi: 10.1007/s11095-022-03396-7. Epub 2022 Sep 26.
3
Tutorial for $DESIGN in NONMEM: Clinical trial evaluation and optimization.
NONMEM 设计教程:临床试验评估与优化。
CPT Pharmacometrics Syst Pharmacol. 2021 Dec;10(12):1452-1465. doi: 10.1002/psp4.12713. Epub 2021 Oct 19.
4
Pharmacometric estimation methods for aggregate data, including data simulated from other pharmacometric models.群体数据的药物代谢动力学估算方法,包括来自其他药物代谢动力学模型模拟的数据。
J Pharmacokinet Pharmacodyn. 2021 Oct;48(5):623-638. doi: 10.1007/s10928-021-09760-1. Epub 2021 Jun 22.
5
Optimal sampling strategies for darunavir and external validation of the underlying population pharmacokinetic model.达芦那韦的最佳采样策略及群体药动学模型的外部验证。
Eur J Clin Pharmacol. 2021 Apr;77(4):607-616. doi: 10.1007/s00228-020-03036-2. Epub 2020 Nov 11.
6
Optimizing Dose-Finding Studies for Drug Combinations Based on Exposure-Response Models.基于暴露-反应模型优化药物组合的剂量发现研究。
AAPS J. 2019 Jul 29;21(5):95. doi: 10.1208/s12248-019-0365-3.
7
Reduced and optimized trial designs for drugs described by a target mediated drug disposition model.基于靶标介导药物处置模型的药物的简化和优化试验设计。
J Pharmacokinet Pharmacodyn. 2018 Aug;45(4):637-647. doi: 10.1007/s10928-018-9594-9. Epub 2018 Jun 8.
8
Balancing Antibacterial Efficacy and Reduction in Renal Function to Optimise Initial Gentamicin Dosing in Paediatric Oncology Patients.平衡抗菌疗效和肾功能降低以优化儿科肿瘤患者初始庆大霉素剂量。
AAPS J. 2017 Dec 4;20(1):14. doi: 10.1208/s12248-017-0173-6.
9
The effect of using a robust optimality criterion in model based adaptive optimization.基于模型的自适应优化中使用鲁棒最优准则的效果。
J Pharmacokinet Pharmacodyn. 2017 Aug;44(4):317-324. doi: 10.1007/s10928-017-9521-5. Epub 2017 Apr 6.
10
The effect of Fisher information matrix approximation methods in population optimal design calculations.Fisher 信息矩阵逼近方法在群体最优设计计算中的影响。
J Pharmacokinet Pharmacodyn. 2016 Dec;43(6):609-619. doi: 10.1007/s10928-016-9499-4. Epub 2016 Nov 1.